TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36536470

Group type: EXPERIMENTAL
Intervention: Transfer of day 6 blastocysts on the 7th day of progesterone supplementation
Number of subjects: 900

Group type: COMPARATOR
Intervention: Transfer of day 6 blastocysts on the 6th day of progesterone supplementation
Number of subjects: 900
Study: 36536472

Group type: EXPERIMENTAL
Intervention: Neoadjuvant nivolumab
Number of subjects: 29
Study: 36536625

Group type: EXPERIMENTAL
Intervention: Self-hypnosis audio file
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo audio file
Number of subjects: 46
Study: 36536736

Group type: EXPERIMENTAL
Intervention: Indocyanine green (ICG) fluorescence angiography
Number of subjects: 30
Study: 36536916

Group type: EXPERIMENTAL
Intervention: Psilocybin (single dose)
Number of subjects: 1
Study: 36537193

Group type: EXPERIMENTAL
Intervention: Pain and Symptom Assessment Tool (Widespread Pain Index - WPI; 0-18 pain locations)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Symptom Severity checklist (SS; 0-12)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Self-report measures of pain intensity, functional impairment, and psychological functioning
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Correlation analysis of WPI and SS scores
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Assessment of psychological factors
Number of subjects: 203
Study: 36537204

Group type: EXPERIMENTAL
Intervention: Mobocertinib (160 mg once daily)
Number of subjects: 257
Study: 36537290

Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) using a lumen-apposing metal stent (LAMS)
Number of subjects: 30
Study: 36537346

Group type: EXPERIMENTAL
Intervention: ABBV-47D11 (180, 600, or 2400 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ABBV-47D11 (600 mg or higher)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ABBV-47D11 (any dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ABBV-47D11
Number of subjects: 0
Study: 36537360

Group type: EXPERIMENTAL
Intervention: Polysubstance use
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alcohol only
Number of subjects: 0
Study: 36537742

Group type: EXPERIMENTAL
Intervention: KN015 (20 μg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: KN015 (40 μg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: KN015 (60 μg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: KN015
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36537785

Group type: EXPERIMENTAL
Intervention: Green kiwifruit (2 kiwifruits per day)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Psyllium (7.5 g per day)
Number of subjects: 184
Study: 36537851

Group type: EXPERIMENTAL
Intervention: Ultrasound-assisted resection
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional resection
Number of subjects: 34
Study: 36537898

Group type: EXPERIMENTAL
Intervention: Cortical Thickness Index (CTI) with cutoff ≤0.50
Number of subjects: 247

Group type: COMPARATOR
Intervention: DXA T-score at total hip
Number of subjects: 247

Group type: COMPARATOR
Intervention: DXA T-score at femoral neck
Number of subjects: 247

Group type: COMPARATOR
Intervention: DXA T-score at lumbar spine
Number of subjects: 247

Group type: COMPARATOR
Intervention: DXA T-score at forearm
Number of subjects: 247
Study: 36538094

Group type: EXPERIMENTAL
Intervention: Subgingival air-polishing with erythritol powder
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional treatment (control group)
Number of subjects: 40
Study: 36538098

Group type: EXPERIMENTAL
Intervention: Clozapine treatment (no specific treatment for hypersalivation)
Number of subjects: 130
Study: 36538139

Group type: EXPERIMENTAL
Intervention: Resiliency intervention
Number of subjects: 24
Study: 36538160

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 36538166

Group type: EXPERIMENTAL
Intervention: High-loading intervention (training at ~90% of the MVC) (n=15)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Eccentric exercise (according to the Alfredson protocol) (n=15)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Passive therapy (n=14)
Number of subjects: 39
Study: 36538189

Group type: EXPERIMENTAL
Intervention: Exercise + High-Intensity Laser Therapy (HILT)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Exercise + Dry Needling
Number of subjects: 108

Group type: COMPARATOR
Intervention: Exercise
Number of subjects: 108
Study: 36538259

Group type: EXPERIMENTAL
Intervention: Mitazalimab (600 μg/kg)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Mitazalimab (2000 μg/kg)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Mitazalimab (with corticosteroids)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Mitazalimab (without corticosteroids)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Mitazalimab
Number of subjects: 95
Study: 36538311

Group type: EXPERIMENTAL
Intervention: Community health worker-delivered hearing care intervention (n=78)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Wait-list control group (n=73)
Number of subjects: 151
Study: 36538309

Group type: EXPERIMENTAL
Intervention: ICE care model (risk-stratified, multidisciplinary intervention combining physical therapy, health coach counseling, and specialist consultation)
Number of subjects: 2971

Group type: EXPERIMENTAL
Intervention: Individualized postural therapy (IPT, combining physical therapy with self-efficacy and self-management)
Number of subjects: 2971

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2971
Study: 36538328

Group type: EXPERIMENTAL
Intervention: 12 weekly, 30-minute virtual health coach sessions + 11 weekly cooking videos and associated home-delivered groceries
Number of subjects: 123
Study: 36538333

Group type: EXPERIMENTAL
Intervention: Functional Gait Assessment (FGA)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: High Level Mobility Assessment Tool (HiMAT)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: 4-Item Hybrid Assessment of Mobility for mTBI (HAM-4-mTBI)
Number of subjects: 53
Study: 36538383

Group type: EXPERIMENTAL
Intervention: Instrument-assisted soft-tissue mobilization (IASTM)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study: 36538392

Group type: EXPERIMENTAL
Intervention: Kinesio Taping
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control (no taping)
Number of subjects: 38
Study: 36538409

Group type: EXPERIMENTAL
Intervention: ExPlas (exercise-trained plasma) transfusion from young, healthy, fit adults, administered once a month for 4 months.
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ExPlas (exercise-trained plasma) transfusion
Number of subjects: 30
Study: 36538418

Group type: EXPERIMENTAL
Intervention: Overground locomotor training (OLT)
Number of subjects: 12
Study: 36538580

Group type: EXPERIMENTAL
Intervention: Transcatheter AVR
Number of subjects: 3403

Group type: EXPERIMENTAL
Intervention: Surgical AVR
Number of subjects: 3403

Group type: EXPERIMENTAL
Intervention: Composite rehospitalization (heart failure, valve-related, or procedure-related causes)
Number of subjects: 3403

Group type: EXPERIMENTAL
Intervention: Heart failure hospitalization after AVR
Number of subjects: 3403

Group type: EXPERIMENTAL
Intervention: Heart failure hospitalization and rehospitalization after AVR
Number of subjects: 3403
Study: 36538596

Group type: EXPERIMENTAL
Intervention: Multimodality and multiparametric model combining 2 imaging indices with natriuretic peptides (BNP or NT-proBNP)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Current echocardiography-based indications for aortic regurgitation surgery
Number of subjects: 127
Study: 36538630

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass or vertical sleeve gastrectomy
Number of subjects: 217
Study: 36538782

Group type: EXPERIMENTAL
Intervention: Soticlestat (100 mg twice daily, titrated up to 300 mg twice daily)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Soticlestat
Number of subjects: 24
Study: 36539060

Group type: EXPERIMENTAL
Intervention: Enhanced retention strategies
Number of subjects: 244

Group type: COMPARATOR
Intervention: Standard retention strategies (non-retention group)
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Retention strategies exposure
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Baseline executive function composite score
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Chronic pain diagnosis
Number of subjects: 244
Study: 36539061

Group type: EXPERIMENTAL
Intervention: Tailored Best Practices (TBP) - evidence-based COVID-19 infection prevention practices adapted for residents with SMI and ID/DD and GH staff.
Number of subjects: 400

Group type: COMPARATOR
Intervention: General Best Practices (GBP) - required standard of care reflecting state and federal standard general guidelines for COVID-19 prevention in GHs.
Number of subjects: 400
Study: 36539157

Group type: EXPERIMENTAL
Intervention: Morning exercise (AMEx) at 10:30
Number of subjects: 16

Group type: COMPARATOR
Intervention: Evening exercise (PMEx) at 18:30
Number of subjects: 16
Study: 36539217

Group type: EXPERIMENTAL
Intervention: LASIK
Number of subjects: 40

Group type: COMPARATOR
Intervention: SMILE
Number of subjects: 40
Study: 36539568

Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Continuous positive airway pressure
Number of subjects: 30
Study: 36539590

Group type: EXPERIMENTAL
Intervention: Frailty index (deficit accumulation)
Number of subjects: 100
Study: 36539711

Group type: EXPERIMENTAL
Intervention: 15 mg/hour intravenous clazosentan
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study: 36539734

Group type: EXPERIMENTAL
Intervention: Therapeutic drug monitoring (TDM) group
Number of subjects: 140

Group type: COMPARATOR
Intervention: Care as usual (CAU) group
Number of subjects: 140
Study: 36539736

Group type: EXPERIMENTAL
Intervention: Chlorhexidine mouthrinse (0.12% chlorhexidine gluconate, gargled for 1 minute with 100 mL)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Usual care (no chlorhexidine mouthrinse)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Chlorhexidine mouthrinse
Number of subjects: 106

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 106
Study: 36539741

Group type: EXPERIMENTAL
Intervention: Training and practice in family involvement
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Standardisation of family involvement practices
Number of subjects: 75
Study: 36539753

Group type: EXPERIMENTAL
Intervention: Family web-based nutrition intervention
Number of subjects: 43

Group type: COMPARATOR
Intervention: Web-based general nutrition guidelines (control)
Number of subjects: 43
Study: 36539781

Group type: EXPERIMENTAL
Intervention: Prophylactic PEG tube placement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reactive PEG tube placement
Number of subjects: 0
Study: 36539791

Group type: EXPERIMENTAL
Intervention: Vitamin K2 supplementation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 36539794

Group type: EXPERIMENTAL
Intervention: WORKWELL programme (job retention vocational rehabilitation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Written self-help information only (control)
Number of subjects: 0
Study: 36539810

Group type: EXPERIMENTAL
Intervention: 40-mg dose of doxycycline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 200-mg antibiotic dose of doxycycline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36539846

Group type: EXPERIMENTAL
Intervention: smartphone condition
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: VR condition
Number of subjects: 240

Group type: COMPARATOR
Intervention: active control condition
Number of subjects: 240
Study: 36539857

Group type: EXPERIMENTAL
Intervention: Comprehensive transfer program for parents (includes an informative website, bi-annual online educational events, and transfer consultations)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 62
Study: 36539897

Group type: EXPERIMENTAL
Intervention: Plant- or insect-based protein from the intervention foods
Number of subjects: 80
Study: 36539907

Group type: EXPERIMENTAL
Intervention: Central IV
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Intracoronary (IC)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Peripheral IV
Number of subjects: 158
Study: 36539913

Group type: EXPERIMENTAL
Intervention: Mixed delirium
Number of subjects: 1564

Group type: EXPERIMENTAL
Intervention: Hypoactive delirium
Number of subjects: 1564

Group type: COMPARATOR
Intervention: Non-delirious patients
Number of subjects: 1564
Study: 36539949

Group type: EXPERIMENTAL
Intervention: DRP prevention bundle
Number of subjects: 769

Group type: COMPARATOR
Intervention: Standard pharmaceutical care (Control)
Number of subjects: 769
Study: 36540016

Group type: EXPERIMENTAL
Intervention: Aspiration during intramuscular injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: No aspiration during intramuscular injection
Number of subjects: 0
Study: 36540034

Group type: EXPERIMENTAL
Intervention: FFR-guided PCI (FFR ≤0.80)
Number of subjects: 562

Group type: COMPARATOR
Intervention: Angiography-guided PCI (diameter stenosis of >50%)
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: FFR-guided PCI
Number of subjects: 562

Group type: COMPARATOR
Intervention: Angiography-guided PCI
Number of subjects: 562
Study: 36541117

Group type: EXPERIMENTAL
Intervention: Chemotherapy + Radiotherapy (CMT)
Number of subjects: 1478

Group type: COMPARATOR
Intervention: Chemotherapy (C)
Number of subjects: 1478
Study: 36541125

Group type: EXPERIMENTAL
Intervention: Malnutrition Universal Screening Tool (MUST) score
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Nutritional Risk Index (NRI)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Nutritional Risk Score 2002 (NRS-2002)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Comprehensive Complication Index
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: EQ-5D-5L
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Time to restart enteral intake
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Time without enteral intake
Number of subjects: 59
Study: 36541257

Group type: EXPERIMENTAL
Intervention: Cold-stored platelets (1°C-6°C) with a maximum storage duration of 21 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard room temperature-stored platelets (20°C-24°C) with a maximum storage duration of 7 days
Number of subjects: 0
Study: 36541390

Group type: EXPERIMENTAL
Intervention: Heart-shaped intrauterine balloon inserted immediately after hysteroscopic adhesiolysis, left in place for 7 days under antibiotic prophylaxis.
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Heart-shaped intrauterine balloon
Number of subjects: 10
Study: 36541393

Group type: EXPERIMENTAL
Intervention: Subthreshold micropulse laser
Number of subjects: 266

Group type: COMPARATOR
Intervention: Standard threshold macular laser
Number of subjects: 266
Study: 36541529

Group type: EXPERIMENTAL
Intervention: Exhaled breath condensate (EBC)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Bronchial washes (BWs)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Bronchoalveolar lavages (BALs)
Number of subjects: 82
Study: 36541643

Group type: EXPERIMENTAL
Intervention: Raltegravir (RAL) group
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Raltegravir (RAL) group (subgroup analysis from EFV)
Number of subjects: 41

Group type: COMPARATOR
Intervention: EFV/PI group
Number of subjects: 41
Study: 36541642

Group type: EXPERIMENTAL
Intervention: Plasma OPN (osteopontin) among WWH
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Plasma OPN among WWH
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Plasma OPN among the whole group and WWH
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Plasma OPN among WWH and WWOH
Number of subjects: 20
Study: 36541647

Group type: EXPERIMENTAL
Intervention: Plasma osteopontin levels
Number of subjects: 0
Study: 36541957

Group type: EXPERIMENTAL
Intervention: ibrutinib plus RICE/RVICI
Number of subjects: 51

Group type: COMPARATOR
Intervention: RICE/RVICI
Number of subjects: 51
Study: 36542081

Group type: EXPERIMENTAL
Intervention: CF1 (340 µg dexamethasone)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: CF2 (340 µg dexamethasone)
Number of subjects: 49
Study: 36542086

Group type: EXPERIMENTAL
Intervention: avalglucosidase alfa 20 mg/kg every other week for 6 months
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: avalglucosidase alfa 40 mg/kg every other week for 6 months
Number of subjects: 22

Group type: COMPARATOR
Intervention: alglucosidase alfa (current stable dose) for 6 months
Number of subjects: 22
Study: 36542136

Group type: EXPERIMENTAL
Intervention: Presence of fibrosis (F0, F1, F2)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Severe fibrosis
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Presence and degree of fibrosis
Number of subjects: 169
Study: 36542145

Group type: EXPERIMENTAL
Intervention: Cystine
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Total cysteine (tCys)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Plasma cystine
Number of subjects: 35
Study: 36542204

Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation (CR) - two cognitive trainings/week (Reha1)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Motor rehabilitation - two motor trainings/week (Reha3)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Combined rehabilitation - one cognitive and one motor training/week (Reha2)
Number of subjects: 48
Study: 36542257

Group type: EXPERIMENTAL
Intervention: Hydrophobic acrylic diffractive trifocal intraocular lens (IOL) with double C-loop haptics
Number of subjects: 23
Study: 36542261

Group type: EXPERIMENTAL
Intervention: Continuous terlipressin infusion (CONI), 4 mg/24 h for 5 days
Number of subjects: 110

Group type: COMPARATOR
Intervention: Intravenous bolus terlipressin (BOL), 2 mg every 4 h
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Continuous terlipressin infusion (CONI)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Intravenous bolus terlipressin (BOL)
Number of subjects: 110
Study: 36542260

Group type: EXPERIMENTAL
Intervention: Once-weekly semaglutide
Number of subjects: 211
Study: 36542287

Group type: EXPERIMENTAL
Intervention: Insulin peglispro
Number of subjects: 857

Group type: COMPARATOR
Intervention: Current case report form (CRF)
Number of subjects: 857
Study: 36542308

Group type: EXPERIMENTAL
Intervention: PVO-OS (0.025, 0.05, or 0.10 mg/mL)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Vehicle (placebo-to-match PVO-OS)
Number of subjects: 36
Study: 36542382

Group type: EXPERIMENTAL
Intervention: Thrice-weekly structured exercise
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Once-weekly structured exercise
Number of subjects: 357

Group type: COMPARATOR
Intervention: Usual care (advice only)
Number of subjects: 357
Study: 36542401

Group type: EXPERIMENTAL
Intervention: Smartphone-based self-management intervention (LiveWell)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 205
Study: 36542425

Group type: EXPERIMENTAL
Intervention: JomPrEP app (clinic-integrated mobile health intervention)
Number of subjects: 0
Study: 36542453

Group type: EXPERIMENTAL
Intervention: Inorganic sunscreen
Number of subjects: 44

Group type: COMPARATOR
Intervention: Organic sunscreen
Number of subjects: 44
Study: 36542513

Group type: EXPERIMENTAL
Intervention: Intrauterine manipulator
Number of subjects: 170

Group type: COMPARATOR
Intervention: Curettage
Number of subjects: 170

Group type: COMPARATOR
Intervention: Hysteroscopy
Number of subjects: 170
Study: 36542596

Group type: EXPERIMENTAL
Intervention: Integrated care model featuring a four-step comprehensive geriatric assessment (screening, multi-dimensional assessment, coordinated individualized care plan, follow-up)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Outreach strategies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implementation costs
Number of subjects: 0
Study: 36542689

Group type: EXPERIMENTAL
Intervention: Unicompartmental knee arthroplasty (UKA)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Total knee arthroplasty (TKA)
Number of subjects: 99
Study: 36542692

Group type: EXPERIMENTAL
Intervention: DS-Cav1 (prefusion) vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: MEDI7510 (postfusion) vaccine
Number of subjects: 0
Study: 36542760

Group type: EXPERIMENTAL
Intervention: Opioids
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Chronic primary pain (ICD-11 classification)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Chronic widespread pain
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Nonspecific pain from the back
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Chronic pain caused by osteoarthritis
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Chronic pain caused by stroke
Number of subjects: 262
Study: 36542826

Group type: EXPERIMENTAL
Intervention: Lisocabtagene maraleucel (liso-cel) - 100 × 10^6 chimeric antigen receptor-positive T cells
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Lisocabtagene maraleucel (liso-cel)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Standard of care (SOC) - 3 cycles of platinum-based immunochemotherapy followed by high-dose chemotherapy and ASCT in responders
Number of subjects: 184
Study: 36543503

Group type: EXPERIMENTAL
Intervention: 7-day ECG patch screening
Number of subjects: 0
Study: 36543719

Group type: EXPERIMENTAL
Intervention: Digital intervention (DI) for chronic low back pain for 12 weeks
Number of subjects: 560
Study: 36544079

Group type: EXPERIMENTAL
Intervention: Functional Electrical Stimulation (FES)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (healthy adults)
Number of subjects: 32
Study: 36544130

Group type: EXPERIMENTAL
Intervention: Chronic musculoskeletal pain (CMP) patients
Number of subjects: 969

Group type: COMPARATOR
Intervention: No chronic musculoskeletal pain (no-CMP) patients
Number of subjects: 969

Group type: EXPERIMENTAL
Intervention: CMP patients
Number of subjects: 969
Study: 36544166

Group type: EXPERIMENTAL
Intervention: 24 blood pressure measurement education sessions using WhatsApp
Number of subjects: 70

Group type: COMPARATOR
Intervention: Routine education using traditional lecture
Number of subjects: 70
Study: 36544184

Group type: EXPERIMENTAL
Intervention: Lecanemab 10 mg/kg biweekly
Number of subjects: 856

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 856
Study: 36544208

Group type: EXPERIMENTAL
Intervention: Standard care and peer-group support in an online instant messaging app (n=15)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Standard care (n=18)
Number of subjects: 33